Novo Nordisk Pharmaceuticals
Executive Summary
Ken Capuano to president of U.S. operations of the Danish biotechnology company. Capuano, 47, who previously was managing director of Novo Nordisk in Australia, succeeds Henk Bleeker, who is returning on assignment to Europe